The UK is witnessing a remarkable shift in its attitude towards mind-altering substances. What began with a subtle exploration of psilocybin and classic Ayahuasca is now developing to feature lesser-known substances like copyright and though research into clinical uses. This rising interest is powered by a combination of promising findings and a de